NEW YORK (AP) — Newspaper publisher Tronc has acquired the Daily News, a storied New York tabloid newspaper that won a Pulitzer Prize this year but has been buffeted by the changing media environment.Chicago-based Tronc Inc., the publisher of the Los Angeles Times and the Chicago Tribune, announced the deal Monday night, and the Daily News posted a story on its website.Tronc CEO Justin Dearborn said acquiring the paper and its popular website would "provide us with another strategic platform for growing our digital business, expanding our reach and broadening our services for advertisers and marketers," and both Tronc and Daily News executives said the company would maintain the quality of the paper's journalism.
NYS Entity Status
NYS Filing Date
FEBRUARY 06, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - BREATHE TREATMENT SERVICES INC.
Around the Web
- Publisher Tronc acquires Daily News, storied NY tabloid
By JENNIFER PELTZ, Associated Press - Monday Sep 4, 2017
- 'NY Times' Finally Joins Snapchat Discover
Monday Apr 24, 2017
Does The New York Times joining Snapchat Discover lend an air of respectability to a new platform, and breathe new life into an aging publisher? That's obviously what the partners are planning -- butonly time will tell.
- Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
By David Holley - Tuesday Jun 20, 2017
Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]
- Inside New York City’s Priciest Rentals
By CAROLINE BIGGS - Friday Sep 1, 2017
Some New Yorkers could afford to buy multimillion-dollar properties, but they’d rather rent a place for upward of $20,000 a month.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]